National Medicines Information Centre (NMIC) Updates

The third NMIC bulletin of 2024 focuses on the ‘Use of medicines with anticholinergic activity’

NMIC Therapeutics Today (May-Number 5): In addition to its regular features, this month’s edition focuses on:

• Risk of adverse events following initiation of antihypertensives in people with complex health needs
• Age-related risk of serious fall events and opioid analgesic use
• Use of progestogens and the risk of intracranial meningioma
• Recent NMIC Bulletins on Breast cancer and Prostate cancer
• Guidance, advice and suggested reading documents
• NMIC CPD module

Previous editions of the Therapeutics Today newsletters, and NMIC therapeutic bulletins are also available on the NMIC website.